A part-randomized study of intravenous oseltamivir in adolescents and adults.

Author: BurleighL, ChappeyC, GiraudonM, VárkonyiI

Paper Details 
Original Abstract of the Article :
Seriously ill patients with influenza may be unable to take oral medication. The safety of intravenous oseltamivir was evaluated in adults and adolescents. This prospective, part-randomized study enrolled hospitalized patients aged ≥13 years with clinical or laboratory-confirmed influenza, who start...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s10096-015-2338-5

データ提供:米国国立医学図書館(NLM)

A part-randomized study of intravenous oseltamivir in adolescents and adults

Influenza, a common respiratory illness, can sometimes take a serious turn, requiring hospitalization and intravenous treatment. This study examines the safety and efficacy of intravenous oseltamivir, an antiviral medication, for treating influenza in hospitalized adolescents and adults. The researchers designed a part-randomized study to assess the medication's effectiveness and safety in this high-risk population.

Navigating the Flu's Desert Landscape

The study provides evidence that intravenous oseltamivir can be a safe and effective treatment option for hospitalized patients with influenza. The researchers found that intravenous oseltamivir achieved comparable systemic exposures to the approved oral dose, suggesting that it could be a viable alternative for patients unable to take oral medications.

Seeking Relief from the Flu's Grip

This study offers a beacon of hope for patients struggling with severe influenza, providing a safe and effective treatment option for those who are unable to take oral medications. This research helps us better understand the challenges of managing influenza and opens up new possibilities for improving patient care.

Dr.Camel's Conclusion

This study, like a desert oasis offering relief from the scorching sun, provides valuable insights into the use of intravenous oseltamivir for managing influenza. It suggests that this treatment option can be a safe and effective alternative for hospitalized patients, helping them navigate the challenging terrain of illness and recover more quickly.

Date :
  1. Date Completed 2016-01-25
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

25678009

DOI: Digital Object Identifier

10.1007/s10096-015-2338-5

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.